Navigation Links
Regulus Therapeutics and Collaborators from NYU Langone Medical Center Publish New Data Demonstrating Clearance of Cholesterol from Bloodstream and Reduction of Atherosclerotic Plaques through Inhibition of microRNA-33
Date:6/6/2011

cine at Regulus. "These studies establish that antagonizing miR-33 with therapeutic anti-miR oligonucleotides can promote regression of atherosclerosis by increasing levels of HDL-C and promoting reverse cholesterol transport. This new paper, and others we have published recently, supports the development of anti-miR-33 as a potential new therapeutic for dyslipidemias, atherosclerosis, and other related metabolic diseases."

In the study, the impact of miR-33 inhibition was evaluated in low density lipoprotein cholesterol receptor deletion (LDLR-/-) hypercholesterolemic mice with already established atherosclerosis to more closely resemble patients in a clinical setting. The mice were treated weekly for four weeks with subcutaneous injections of 10 mg/kg of anti-miR-33 or control anti-miR oligonucleotides. Anti-miR-33 treatment increased HDL-C and enhanced cholesterol transport from peripheral cells to the liver for further excretion into bile and feces. In addition, anti-miR treated mice had a 35% reduction in lesion area of atherosclerotic plaques. Taken together, the results indicated that anti-miR-33 treatment supports the efflux of cholesterol from lesional macrophages and promotes regression of established atherosclerosis. Importantly, no elevations in serum hepatotoxicity markers, aspartate aminotransferase or alanine aminotransferase (AST/ALT) were observed.  

"Our studies with Regulus show that miR-33 inhibition raises circulating HDL-C, promotes removal of excess cholesterol from atherosclerotic plaques, and favorably affects lesion pathology," said Dr. Moore of NYU Langone. "The data establish miR-33 as an attractive therapeutic target for the treatment of atherosclerotic disease."

Regulus controls fundamental patent rights related to miR-33, including the miR-33 sequence and complementary sequences covered in the Tuschl III patent series. Additional Regulus patent rights include compositions of matter for various chemically modif
'/>"/>

SOURCE Regulus Therapeutics Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
3. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
4. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
5. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
6. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
7. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
8. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
9. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
10. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
11. Cell Therapeutics, Inc. (CTI) Sponsors Panel Discussion on Women and Lung Cancer on Capitol Hill
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... May 21, 2013 STAAR Surgical Company (NASDAQ: ... marketer of minimally invasive ophthalmic products, today announced that ... review the Company,s recent financial results and business developments ... will present at the 38 th Annual Deutsche ... at the Westin Waterfront Hotel on Wednesday, May ...
(Date:5/20/2013)... GENEVA , May 21, 2013 ... Health Assembly, where world,s health ministers gather to address ... Mental and neurological disorders (MNDs) affect 700 ... global non-communicable disease (NCD) burden ,Do You ... understand the role each can play to collectively address ...
(Date:5/20/2013)... Landauer, Inc. (NYSE: LDR ), ... and monitoring, outsourced medical physics services and high quality ... Directors declared, at its meeting on May 16, 2013, ... for the third quarter of fiscal 2013.  The dividend ... of record on June 7, 2013. About ...
Breaking Medicine Technology:STAAR Surgical To Present At Upcoming Investor Conferences 2Research-based Pharmaceutical Industry Launches 'Do You Mind?' Campaign to Fight Mental and Neurological Disorders 2Landauer, Inc. Declares Regular Cash Dividend 2
... March 8, 2012 , Quality of Life ... available treatment fails in two thirds of patients ... Pevion Biotech AG today announced results from a large, ... vulvovaginal candidiasis (RVVC) patients. It is the first time that ...
... Inc. (Nasdaq: BIOD ) today announced that ... will present a corporate update at the ROTH 24th Annual ... 3:00 p.m. Pacific Time (6:00 p.m. Eastern Time). ... Conference will be held March 11-14, 2012, at the ...
Cached Medicine Technology:Pevion Mandated Patient Survey Confirms Disease Burden of Recurrent Vulvovaginal Candidiasis (RVVC) and Indicates Public Health Problem 2Pevion Mandated Patient Survey Confirms Disease Burden of Recurrent Vulvovaginal Candidiasis (RVVC) and Indicates Public Health Problem 3Pevion Mandated Patient Survey Confirms Disease Burden of Recurrent Vulvovaginal Candidiasis (RVVC) and Indicates Public Health Problem 4
(Date:5/21/2013)... significantly more likely than their normal-weight counterparts to ... disrupts continuity of care and leads to more ... , The practice of "doctor shopping" among overweight ... with the health care system, whether that be ... advice by providers, or improperly sized medical equipment ...
(Date:5/21/2013)... Children using the abutment-free implantable bone ... results comparable to the traditionally used, competitive abutment ... to a new study. , “The results are ... performs just as well as technology with a ... says Jim Kasic, president and CEO of Sophono. ...
(Date:5/21/2013)... News) -- Urban elementary school children with poorly ... and suffer academically, new research indicates. "In ... nine, we found that compromised lung function corresponded ... performance," said study author Daphne Koinis-Mitchell, an ... Brown University,s Alpert Medical School in Providence, R.I. ...
(Date:5/21/2013)... nanoparticles are usually toxic to cells, but cancer ... Clinic researchers found out why, and determined how ... cells. The discovery is detailed in the current ... Chemistry ., "This study identifies a novel mechanism ... cell death or apoptosis which should occur when ...
(Date:5/21/2013)... Representatives with Hammerhead Bicycles announced today that ... the company has achieved its overall goal of becoming a ... to move Hammerhead Bicycles from a house brand to a ... , Robertson explained that the bike shop will go forward ... on all things 29er and 650b. , “The ...
Breaking Medicine News(10 mins):Health News:'Doctor shopping' by obese patients negatively affects health 2Health News:'Doctor shopping' by obese patients negatively affects health 3Health News:Abutment-Free Sophono Systems Produce Comparable Study Results to Cochlear’s Baha Products, With Fewer Complications 2Health News:Abutment-Free Sophono Systems Produce Comparable Study Results to Cochlear’s Baha Products, With Fewer Complications 3Health News:Sleepless Nights May Hurt School Performance of Kids With Asthma 2Health News:Mayo Clinic: How gold nanoparticles can help fight ovarian cancer 2Health News:Hammerhead Bicycles Now a Standalone Brand 2
... Medical Record/Practice Management Software Company Aimed at Giving ... HILLS, Mich., May 27 gloStream, a healthcare ... Office embedded electronic medical record ("EMR") and practice ... closed on a $7.5 million series B financing ...
... When Chicago Blackhawk,s leading scorer Martin Havlat returned ... Conference Final after sustaining a concussion only two days ... to a new study by St. Michael,s Hospital neurosurgeon ... of minor league hockey players who did not know ...
... to healthier livesST. LOUIS, May 27 Nurse Response ... new consumer health tool that will complement the quality ... Response will offer the Healthwise Knowledgebase, an online consumer ... to access over 7,000 health topics online. , ...
... York, NY / Los Angeles, CA: Stand Up ... aimed at getting new cancer treatments to patients in ... the first round of three-year grants that total ... Teams. The majority of these funds were raised in ...
... The Institute for Palliative Medicine plays unique roleSAN DIEGO, ... Irwin, M.D., Ph.D., Director of the Palliative Care Psychiatry ... been elected as a Member of The American College ... one of only 750 practicing psychiatrists nationwide who have ...
... for stricter regulatory approval requirements and continuity of product supply. ... ... A recent report released by Wolters Kluwer Health predicts that by ... will be filled with generic drugs. This march to generics ...
Cached Medicine News:Health News:gloStream Announces $7.5 Million Series B Financing Round Co-Led by Beringea and gloStream's Executive Management Team 2Health News:gloStream Announces $7.5 Million Series B Financing Round Co-Led by Beringea and gloStream's Executive Management Team 3Health News:gloStream Announces $7.5 Million Series B Financing Round Co-Led by Beringea and gloStream's Executive Management Team 4Health News:Minor league hockey players unable to identify concussion symptoms, study says 2Health News:Minor league hockey players unable to identify concussion symptoms, study says 3Health News:Stand Up to Cancer awards $73.6 million for novel, groundbreaking cancer research 2Health News:Stand Up to Cancer awards $73.6 million for novel, groundbreaking cancer research 3Health News:Stand Up to Cancer awards $73.6 million for novel, groundbreaking cancer research 4Health News:Stand Up to Cancer awards $73.6 million for novel, groundbreaking cancer research 5Health News:Stand Up to Cancer awards $73.6 million for novel, groundbreaking cancer research 6Health News:Stand Up to Cancer awards $73.6 million for novel, groundbreaking cancer research 7Health News:Stand Up to Cancer awards $73.6 million for novel, groundbreaking cancer research 8Health News:San Diego Psychiatrist Scott Irwin Honored With National Recognition 2Health News:San Diego Psychiatrist Scott Irwin Honored With National Recognition 3Health News:In the Case of Epilepsy, Generic Drugs and Random Product Substitution are Not Always "Good Medicine" 2Health News:In the Case of Epilepsy, Generic Drugs and Random Product Substitution are Not Always "Good Medicine" 3Health News:In the Case of Epilepsy, Generic Drugs and Random Product Substitution are Not Always "Good Medicine" 4Health News:In the Case of Epilepsy, Generic Drugs and Random Product Substitution are Not Always "Good Medicine" 5
VG2 PLIF (Parallel) Posterior lumbar interbody fusion. Frozen preservation. Consists of two outer cortical planks, center cancellous plank, all from the same donor, held together by two press-fit cor...
An all-cortical structure provides the structural benefits of cortical bone. Precision machined to exact specifications to promote healthy lordosis and vertebral body distraction....
Solid cortical spacers with a natural anatomic fibular shape....
... Allografts are comprised of a ... strength and an enlarged center ... of preferred bone graft material ... instruments facilitate the insertion of ...
Medicine Products: